• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Steris begins replacing flagship sterilization systems

Steris begins replacing flagship sterilization systems

December 20, 2010 By MedCity News

STE logo

Steris Corp. (NYSE:STE) has begun shipping the replacement to its System 1 sterilization system, as the company looks to put one of its more difficult periods in its past.

The company said shipments of the new System 1E wouldn’t have a material effect on its third-quarter financial results, but the shipments are nonetheless an important step for Steris, which has spent the last year trying to work its way back from a federal safety alert from Dec. 2009 that said the device could harm patients.

System 1 is a liquid chemical sterilizing system used by hospitals, surgical centers and other healthcare facilities to sterilize medical instruments. The Food & Drug Administration said Steris had changed the System 1 so much since its 1988 launch that the regulator no longer considered it a device approved for sale.

MedCity News logo

The biggest difference between the two sterilization systems is System 1E is restricted to use for sterilizing heat-sensitive devices — endoscopes made with materials or adhesives that degrade when heated — while System 1 can be used to sterilize both devices that are heat sensitive and those that aren’t. Practically, System 1E is able to process between 70 percent and 80 percent of the devices that System 1 can, Steris executives have said.

While System 1E received regulatory clearance for sale in April, Steris didn’t begin shipping the new device because it was waiting for FDA clearance of two accessory parts, even though the company wasn’t required by the FDA to wait.

The company has received clearance on just one of those two accessories, a chemical indicator, while it has not received clearance for the other, a biologic indicator, according to a filing with the Securities and Exchange Commission. The company is in discussions with the FDA about clearance of the biologic indicator.

Up against an August deadline from the FDA to have System 1E in its customers’ hands, Steris decided to ship the product with just one of the accessory clearances in place. “We’ve heard from our customers that they want us to start shipping units as soon as possible,” said Steve Norton, a company spokesman.

During Steris’ quarterly earnings conference call with investors in early November, the company said it had taken more than 1,000 orders for System 1E and provided an additional 7,000 quotes. Steris had produced about 2,000 of the units at the time, and expected to manufacture between 4,000 and 6,000 by the end of the year.

Norton said the company would update those figures during its next quarterly earnings call in February.

Separately, Steris said it had received FDA clearance on its modified Reliance EPS Endoscope Processing System. Like the System 1, the Reliance system had undergone modifications that the FDA felt were significant enough to warrant a new 510(k) application for regulatory clearance. That led to Steris suspending sales of the product in August.

Filed Under: Business/Financial News, News Well, Sterilization / Calibration Tagged With: Gift Bans, Steris Corp.

More recent news

  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy